Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  NuPathe Inc    

NUPATHE INC
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCalendarCompanyFinancials 
Company
NuPathe, Inc. develops pharmaceutical and therapeutic products.The firm focuses on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.The company was founded by Terri B. Sebree and Jane H.... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on NUPATHE INC
2014U.S. HOT STOCKS : Hot Stocks to Watch
DJ
2014NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
PR
2014NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
MW
2014NUPATHE INC : NuPathe Inc. Stockholders Encouraged to Contact Securities Law Fir..
PR
2013NUPATHE INC : Program Participations and Positive Stock Movements - Research Rep..
PR
2013NUPATHE INC : NUPATHE INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investi..
BU
2013NUPATHE INC : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of NU..
PR
2013NUPATHE INC : Harwood Feffer LLP Announces Investigation of NuPathe, Inc.
PR
2013NUPATHE INC : PATH SHAREHOLDER ALERT: The Law Firm of Wohl & Fruchter is Investi..
BU
2013NUPATHE INC : SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces In..
BU
More news
Sector news : Pharmaceuticals - NEC
03:56pINVESCO UK LTD INVESCO LTD. : Form 8.3 - Shire Plc
DJ
03:18pGLAXOSMITHKLINE : 1Q Earnings Impacted by FX Effects -- Earnings Review
DJ
03:11pCurrency and pricing squeeze GSK as new shingles vaccine shines
RE
02:46pShire willing to back $64 billion Takeda bid, market signals doubts
RE
02:16pShire willing to back $64 billion Takeda bid, market signals doubts
RE
More sector news : Pharmaceuticals - NEC
Chart NUPATHE INC
Duration : Period :
NuPathe Inc Technical Analysis Chart | US67059M1009 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Richard S. Egosi President, Chief Executive Officer & Director
Deborah A. Griffin Chief Financial Officer, Treasurer, Director & VP
Austin D. Kim Secretary
Sector and Competitors
1st jan.Capitalization (M$)
NUPATHE INC0
JOHNSON & JOHNSON-9.23%340 239
PFIZER1.60%218 908
NOVARTIS-8.06%203 482
ROCHE HOLDING LTD.-11.08%192 055
MERCK AND COMPANY6.79%162 398